Rephonic
Artwork for ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

American College of Cardiology
Heart Failure
Cardiovascular Disease
Atrial Fibrillation
Cardiology
SGLT2 Inhibitors
Myocardial Infarction
Obesity
Hypertension
Echocardiography
Aspirin
Aortic Stenosis
Lipoprotein A
Therapeutics
Atherosclerotic Cardiovascular Disease
Statin Therapy
Ticagrelor
Artificial Intelligence
Diabetes
Health Disparities
AHA/ACC Perioperative Guidelines

The American College of Cardiology offers select interviews and summaries of cardiology's most interesting research areas from ACCEL's renowned library, hosted by ACCEL Editor-in-Chief Alison L. Bailey, MD, FACC, FAACPVR.

PublishesWeeklyEpisodes300Founded9 years ago
Number of ListenersCategories
MedicineEducationHealth & Fitness

Listen to this Podcast

Artwork for ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Latest Episodes

Nonobstructive hypertrophic cardiomyopathy (HCM) represents one of the greatest areas of unmet need in HCM management. A key question is identifying the primary driver of symptoms in these patients, as many experience significant functional limitatio... more

The VESALIUS-CV trial demonstrated that the PCSK9 inhibitor evolocumab significantly reduced the risk of a first major cardiovascular event in patients with diabetes who had no known significant atherosclerosis. These findings challenge current clini... more

Randomized trials in stable ischemic heart disease (SIHD) show revascularization does not reduce death or myocardial infarction versus guideline-directed medical therapy, with benefit limited to symptom relief. This likely reflects lesion–ischemia mi... more

ecent advancements in echocardiography since ACC.25 highlight a shift toward greater precision, efficiency, and consistency in cardiac imaging. Standardized echo reporting is now recognized as a key marker of quality care, improving communication and... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Nicholas Marston
Assistant Professor of Medicine at the Brigham and Women's Hospital
Brigham and Women's Hospital
Episode: Evolocumab In Patients Without Significant Atherosclerosis: Results From VESALIUS-CV
Sanjay Kaul
Attending cardiologist
Cedars-Sinai Medical Center
Episode: Why Can't We Prove Revascularization Is Better Than Medical Therapy for SIHD?
David Wiener
Clinical Professor of Medicine, Thomas Jefferson University; President of the American Society of Echocardiography
Thomas Jefferson University; American Society of Echocardiography
Episode: Top Practice-Changing Advancements in Echocardiography Since ACC.25
Larry Sperling
Katz Professor in Preventative Cardiology, Emory University
Emory University School of Medicine
Episode: The Case For Medically Tailored Meals
Deepak Bhakta
Cardiologist from the University of Indiana
University of Indiana
Episode: Managing Subclinical AFib Detected by Devices, Ambulatory Monitors and Wearables
Dr. Steven Nissen
Cardiologist, Chief Academic Officer at Seidel and Arnold Miller Family Heart Vascular and Thoracic Institute
Cleveland Clinic
Episode: Cardiorenal Outcomes with Tirzepatide Compared with Dulaglutide in Patients with Diabetes and CVD
Pam Taub
Professor of Medicine, UC San Diego, Cardiology
UC San Diego
Episode: Impact Of Ivabradine in Post-COVID POTS: The Recover-Autonomic Trial
Misa Fister
Inattending physician at University Medical Center at Ljubljana
University Medical Center Ljubljana
Episode: Prehospital Heparin Administration In Patients With STEMI Undergoing Primary PCI
Rob Mentz
Editor of JCF, Duke University clinician
Duke University
Episode: Definitions and Treatment of Iron Deficiency in HF: Feel and Function or More?

Host

Alison Bailey
Editor-in-Chief of ACCEL Lite and a prominent host of interviews with leading cardiology researchers and clinicians.

Reviews

4.1 out of 5 stars from 85 ratings
  • ACCELlent

    I really like this podcast. I disagree with many reviewers that it’s short. It’s the perfect length for listening on a walk or a commute or a break. If you want an hour-long plus podcast then you should be checking out the website or journal.

    Apple Podcasts
    5
    Ramster1
    United States7 months ago
  • Called Lite for a reason; the previous ACCEL was so much better

    I love this podcast, but I miss the breadth and depth of interviews that I used to hear on the original ACCEL/Audio Digest. I felt I could keep up with new developments and thinking by listening to the 3 hours of interviews each month, but now ACCEL is much more limited, thus “Lite.”

    Apple Podcasts
    2
    RandalHu
    United Statesa year ago
  • Superficial

    Compared to previous version of ACCEL this is very superficial and shallow . I miss the old ACCEL with detailed interviews and pdfs . CME was nice too . I would not mind paying for the ACCEL if it is detailed and has CME included. The way it was in the past

    Apple Podcasts
    3
    Harakil
    United States2 years ago
  • Senior-RITA

    The audio of the author is very distorted unfortunately.

    Apple Podcasts
    3
    NebraskanE
    United States2 years ago
  • Timothy Wong's August 2024 presentation

    Timothy Wong's August 2024 presentation on HCM. Dr Wong refers to LVH as a symptom. LVH is a sign or a finding, but it is not a symptom.

    Apple Podcasts
    3
    golgikanji
    United States2 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Listeners appreciate practical takeaways but some want deeper, more in-depth exploration of trials.
The show provides concise, up-to-date clinical updates that fit busy schedules.
Guests are highly credible and the discussion often centers on real-world applicability.
Some episodes are perceived as less depth-heavy compared to prior, longer formats.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Why Can't We Prove Revascularization Is Better Than Medical Therapy for SIHD?
Q: Why might trials not show a clear benefit for revascularization over medical therapy?
Several reasons: trial populations were low-risk and excluded high-risk subsets, there was substantial crossover from medical therapy to revascularization, follow-up was not long enough, ischemia-based selection may miss broader risk modification benefits, and modern medical therapy has become highly effective, reducing incremental gains from revascularization.
Why Can't We Prove Revascularization Is Better Than Medical Therapy for SIHD?
Q: What is the totality of evidence regarding revascularization and medical therapy in stable ischemic heart disease?
Trials over the last 30 years show that invasive strategies do not reduce mortality or mobility beyond what conservative therapy provides, with only a modest, short-term improvement in symptoms and quality of life; optimal medical therapy has improved markedly, and many patients experience symptom relief or stability without revascularization.
The Case For Medically Tailored Meals
Q: Is there actual evidence to support prescribing medically tailored meals, or is this just a logical idea?
There is evidence showing trends toward lower readmissions and better surrogate markers, but existing studies are often small and short, so we need more robust data and clear guidelines on dosage and integration with nutrition counseling.
Impact Of Ivabradine in Post-COVID POTS: The Recover-Autonomic Trial
Q: What were the main results and their implications?
The overall OHQ did not differ between ivabradine and placebo, but there was a signal that adding coordinated care to ivabradine improved outcomes, suggesting a synergistic effect between pharmacologic heart-rate reduction and structured lifestyle interventions in improving quality of life for post-COVID POTS patients.
Impact Of Ivabradine in Post-COVID POTS: The Recover-Autonomic Trial
Q: What was the rationale behind the RECOVER Autonomic Trial?
The trial was designed because there was very little data to guide management of POTS, especially post-COVID related, and there was a need to evaluate whether ivabradine could lower heart rate and improve quality of life, particularly in a population with long COVID and POTS, using a factorial design that also tested coordinated care versus standard lifestyle advice.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About This Podcast

What is This Podcast about and what kind of topics does it cover?

This program features concise, practitioner-focused discussions on cutting-edge cardiovascular research and practice. Episodes cover topics ranging from heart-lung disease phenotypes and novel remodeling therapies to trial design, guideline updates, and real-world implementation of prevention strategies. Guests are often leading clinicians and researchers from top medical centers, providing actionable insights, trial context, and pragmatic takeaways for frontline cardiologists. A notable strength is the blend of clinical relevance with research updates, helping listeners stay current without lengthy interviews, though some feedback suggests a desire for deeper, more in-depth conversations on complex trials and guidelines. The format is well... more

Where can I find podcast stats for this podcast?

Rephonic provides a wide range of podcast stats for this podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to this podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does this podcast get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for this podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for this podcast?

Rephonic provides comprehensive predictive audience data for this podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does this podcast have?

To see how many followers or subscribers this podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to this podcast?

These podcasts share a similar audience with this podcast:

1. Eagle's Eye View: Your Weekly CV Update From ACC.org
2. This Week in Cardiology
3. ACC CardiaCast
4. Cardionerds: A Cardiology Podcast
5. Mayo Clinic Cardiovascular CME

How many episodes of this podcast are there?

this podcast launched 9 years ago and published 300 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact this podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for this podcast?

Rephonic pulls ratings and reviews for this podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for this podcast?

Rephonic provides full transcripts for episodes of this podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on this podcast?

Recent guests on this podcast include:

1. Nicholas Marston
2. Sanjay Kaul
3. David Wiener
4. Larry Sperling
5. Deepak Bhakta
6. Dr. Steven Nissen
7. Pam Taub
8. Misa Fister

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days